Filter by
 

Origin

Publication date

Category

Main subject

Main subject

Keywords

Keywords

Geographical scope

Document language

EMCDDA Document Library

Displaying 1 - 10 of 31

Commission Delegated Directive (EU) 2022/1326 of 18 March 2022 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’

March 2022

The Commission Delegated Directive (EU) 2022/1326 is amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’.

Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA

June 2021

This document links to the Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA.

Commission Delegated Directive on isotonitazene

November 2020

Isotonitazene is a synthetic opioid analgesic and is closely related to etonitazene and clonitazene, both of which are under international control under the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol. This document is the Commission Delegated Directive...

Council Decision on cyclopropylfentanyl and methoxyacetylfentanyl

September 2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats (2)(3). The...

Council Decision on ADB-CHMINACA

May 2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substance...

Council Decision on CUMYL-4CN-BINACA

May 2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substance...

Regulation (EU) 2017/2101

November 2017

The legislation includes a stronger EU Early Warning System (EWS) and a faster risk-assessment process. The developments are in response to the recent growth in the market in NPS and follow a proposal from the European Commission (EC) comprising: a Regulation regarding information exchange on, and...

Council Decision on furanylfentanyl

November 2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substance...

Council Decision on acryloylfentanyl

September 2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substance...

Council Decision on MDMB-CHMICA

February 2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substance...

Loading